726 related articles for article (PubMed ID: 12829834)
1. The Ebola virus VP35 protein inhibits activation of interferon regulatory factor 3.
Basler CF; Mikulasova A; Martinez-Sobrido L; Paragas J; Mühlberger E; Bray M; Klenk HD; Palese P; García-Sastre A
J Virol; 2003 Jul; 77(14):7945-56. PubMed ID: 12829834
[TBL] [Abstract][Full Text] [Related]
2. Ebola virus VP35 protein binds double-stranded RNA and inhibits alpha/beta interferon production induced by RIG-I signaling.
Cárdenas WB; Loo YM; Gale M; Hartman AL; Kimberlin CR; Martínez-Sobrido L; Saphire EO; Basler CF
J Virol; 2006 Jun; 80(11):5168-78. PubMed ID: 16698997
[TBL] [Abstract][Full Text] [Related]
3. The VP35 protein of Ebola virus inhibits the antiviral effect mediated by double-stranded RNA-dependent protein kinase PKR.
Feng Z; Cerveny M; Yan Z; He B
J Virol; 2007 Jan; 81(1):182-92. PubMed ID: 17065211
[TBL] [Abstract][Full Text] [Related]
4. Reverse genetic generation of recombinant Zaire Ebola viruses containing disrupted IRF-3 inhibitory domains results in attenuated virus growth in vitro and higher levels of IRF-3 activation without inhibiting viral transcription or replication.
Hartman AL; Dover JE; Towner JS; Nichol ST
J Virol; 2006 Jul; 80(13):6430-40. PubMed ID: 16775331
[TBL] [Abstract][Full Text] [Related]
5. The Ebola virus VP35 protein functions as a type I IFN antagonist.
Basler CF; Wang X; Mühlberger E; Volchkov V; Paragas J; Klenk HD; García-Sastre A; Palese P
Proc Natl Acad Sci U S A; 2000 Oct; 97(22):12289-94. PubMed ID: 11027311
[TBL] [Abstract][Full Text] [Related]
6. Ebola virus protein VP35 impairs the function of interferon regulatory factor-activating kinases IKKepsilon and TBK-1.
Prins KC; Cárdenas WB; Basler CF
J Virol; 2009 Apr; 83(7):3069-77. PubMed ID: 19153231
[TBL] [Abstract][Full Text] [Related]
7. Herpes simplex virus 1 has multiple mechanisms for blocking virus-induced interferon production.
Melroe GT; DeLuca NA; Knipe DM
J Virol; 2004 Aug; 78(16):8411-20. PubMed ID: 15280450
[TBL] [Abstract][Full Text] [Related]
8. Identification of the rabies virus alpha/beta interferon antagonist: phosphoprotein P interferes with phosphorylation of interferon regulatory factor 3.
Brzózka K; Finke S; Conzelmann KK
J Virol; 2005 Jun; 79(12):7673-81. PubMed ID: 15919920
[TBL] [Abstract][Full Text] [Related]
9. Effects of Filovirus Interferon Antagonists on Responses of Human Monocyte-Derived Dendritic Cells to RNA Virus Infection.
Yen BC; Basler CF
J Virol; 2016 May; 90(10):5108-5118. PubMed ID: 26962215
[TBL] [Abstract][Full Text] [Related]
10. Evasion of interferon responses by Ebola and Marburg viruses.
Basler CF; Amarasinghe GK
J Interferon Cytokine Res; 2009 Sep; 29(9):511-20. PubMed ID: 19694547
[TBL] [Abstract][Full Text] [Related]
11. Interferon regulatory factor 7 is negatively regulated by the Epstein-Barr virus immediate-early gene, BZLF-1.
Hahn AM; Huye LE; Ning S; Webster-Cyriaque J; Pagano JS
J Virol; 2005 Aug; 79(15):10040-52. PubMed ID: 16014964
[TBL] [Abstract][Full Text] [Related]
12. The N- and C-terminal domains of the NS1 protein of influenza B virus can independently inhibit IRF-3 and beta interferon promoter activation.
Donelan NR; Dauber B; Wang X; Basler CF; Wolff T; García-Sastre A
J Virol; 2004 Nov; 78(21):11574-82. PubMed ID: 15479798
[TBL] [Abstract][Full Text] [Related]
13. Activation of interferon regulatory factor 3 is inhibited by the influenza A virus NS1 protein.
Talon J; Horvath CM; Polley R; Basler CF; Muster T; Palese P; García-Sastre A
J Virol; 2000 Sep; 74(17):7989-96. PubMed ID: 10933707
[TBL] [Abstract][Full Text] [Related]
14. Identification of the minimal phosphoacceptor site required for in vivo activation of interferon regulatory factor 3 in response to virus and double-stranded RNA.
Servant MJ; Grandvaux N; tenOever BR; Duguay D; Lin R; Hiscott J
J Biol Chem; 2003 Mar; 278(11):9441-7. PubMed ID: 12524442
[TBL] [Abstract][Full Text] [Related]
15. Primary activation of interferon A and interferon B gene transcription by interferon regulatory factor 3.
Juang YT; Lowther W; Kellum M; Au WC; Lin R; Hiscott J; Pitha PM
Proc Natl Acad Sci U S A; 1998 Aug; 95(17):9837-42. PubMed ID: 9707562
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of IRF-3 activation by VP35 is critical for the high level of virulence of ebola virus.
Hartman AL; Bird BH; Towner JS; Antoniadou ZA; Zaki SR; Nichol ST
J Virol; 2008 Mar; 82(6):2699-704. PubMed ID: 18199658
[TBL] [Abstract][Full Text] [Related]
17. A Luciferase Reporter Gene Assay to Measure Ebola Virus Viral Protein 35-Associated Inhibition of Double-Stranded RNA-Stimulated, Retinoic Acid-Inducible Gene 1-Mediated Induction of Interferon β.
Cannas V; Daino GL; Corona A; Esposito F; Tramontano E
J Infect Dis; 2015 Oct; 212 Suppl 2():S277-81. PubMed ID: 25926684
[TBL] [Abstract][Full Text] [Related]
18. Virus-dependent phosphorylation of the IRF-3 transcription factor regulates nuclear translocation, transactivation potential, and proteasome-mediated degradation.
Lin R; Heylbroeck C; Pitha PM; Hiscott J
Mol Cell Biol; 1998 May; 18(5):2986-96. PubMed ID: 9566918
[TBL] [Abstract][Full Text] [Related]
19. C and V proteins of Sendai virus target signaling pathways leading to IRF-3 activation for the negative regulation of interferon-beta production.
Komatsu T; Takeuchi K; Yokoo J; Gotoh B
Virology; 2004 Jul; 325(1):137-48. PubMed ID: 15231393
[TBL] [Abstract][Full Text] [Related]
20. Homo-oligomerization facilitates the interferon-antagonist activity of the ebolavirus VP35 protein.
Reid SP; Cárdenas WB; Basler CF
Virology; 2005 Oct; 341(2):179-89. PubMed ID: 16095644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
